SCHEMBL3777424

SCHEMBL3777424

C=C[Si](C)(C)C(C)N(C1CCCC1)C1CCCC1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.34
ADH1C P00326 1/20 0.34
ADH1A P07327 1/20 0.34
FDPS P14324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3771974 0.98 ADH1C (0.37) ADH1BADH1CADH1AFDPS
SCHEMBL3776316 0.77 ADH1A (0.32) ADH1CADH1A
SCHEMBL3772017 0.76 ADH1A (0.35) ADH1BADH1CADH1AFDPS
SCHEMBL3781845 0.66
SCHEMBL3774398 0.64
SCHEMBL12250816 0.63 ADH1A (0.56) ADH1BADH1CADH1AFDPS
SCHEMBL12250814 0.63 ADH1A (0.56) ADH1BADH1CADH1AFDPS
SCHEMBL2476512 0.63 ADH1A (0.56) ADH1BADH1CADH1AFDPS
SCHEMBL737870 0.63 ADH1C (0.35) ADH1BADH1CADH1AFDPS
SCHEMBL25171957 0.63 ADH1A (0.40) ADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436166-B2 Amino-containing vinylsilane compounds and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-07 US disclosed
US-20100317852-A1 AMINO-CONTAINING VINYLSILANE COMPOUNDS AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317852-A1 AMINO-CONTAINING VINYLSILANE COMPOUNDS AND MAKING METHOD BHMT2, GNMT, VASP ADH1B 3831/4885ADH1C 4556/4885ADH1A 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.